Neurokinin B Administration Induces Hot Flushes in Women

[1]  J. Manson,et al.  Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. , 2014, JAMA internal medicine.

[2]  M. Hunter,et al.  Symptom perception in healthy menopausal women: Can we predict concordance between subjective and physiological measures of vasomotor symptoms? , 2014, American journal of human biology : the official journal of the Human Biology Council.

[3]  Fredi Kronenberg,et al.  Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events , 2014, Physiological measurement.

[4]  G. Stamp,et al.  Effects of Neurokinin B Administration on Reproductive Hormone Secretion in Healthy Men and Women , 2013, The Journal of clinical endocrinology and metabolism.

[5]  L. Sievert.  Subjective and objective measures of hot flashes , 2013, American journal of human biology : the official journal of the Human Biology Council.

[6]  T. Pantoja,et al.  Non-hormonal interventions for hot flushes in women with a history of breast cancer , 2010, The Cochrane database of systematic reviews.

[7]  R. Lobo,et al.  Global Consensus Statement on menopausal hormone therapy. , 2013, Maturitas.

[8]  M. Hunter,et al.  Health-related quality of life of women with menopausal hot flushes and night sweats , 2013, Climacteric : the journal of the International Menopause Society.

[9]  N. Rance,et al.  Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature , 2012, Proceedings of the National Academy of Sciences.

[10]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[11]  N. Rance,et al.  Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat. , 2011, Endocrinology.

[12]  A. Maclennan,et al.  Menopausal hot flushes and night sweats: where are we now? , 2011, Climacteric : the journal of the International Menopause Society.

[13]  Myra S. Hunter,et al.  Concordance between self-reported and sternal skin conductance measures of hot flushes in symptomatic perimenopausal and postmenopausal women: a systematic review , 2011, Menopause.

[14]  A. LaCroix,et al.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. , 2011, JAMA.

[15]  R. Quinton,et al.  TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. , 2010, The Journal of clinical endocrinology and metabolism.

[16]  S. Morrison,et al.  A thermosensory pathway mediating heat-defense responses , 2010, Proceedings of the National Academy of Sciences.

[17]  Clifford B. Saper,et al.  Parallel Preoptic Pathways for Thermoregulation , 2009, The Journal of Neuroscience.

[18]  V. Stearns,et al.  Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy , 2009, Menopause.

[19]  Frank Reimann,et al.  TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction , 2009, Nature Genetics.

[20]  L. Coolen,et al.  Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. , 2007, Endocrinology.

[21]  M. Voytko,et al.  Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. , 2007, Journal of Clinical Endocrinology and Metabolism.

[22]  E. Freeman,et al.  Prevalence of hot flushes and night sweats around the world: a systematic review , 2007, Climacteric : the journal of the International Menopause Society.

[23]  G. Kelly,et al.  Body temperature variability (Part 1): a review of the history of body temperature and its variability due to site selection, biological rhythms, fitness, and aging. , 2006, Alternative medicine review : a journal of clinical therapeutic.

[24]  W. Spooren,et al.  NK3 receptor antagonists: the next generation of antipsychotics? , 2005, Nature Reviews Drug Discovery.

[25]  N. Page.  New challenges in the study of the mammalian tachykinins , 2005, Peptides.

[26]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[27]  C. Loprinzi,et al.  Treatment of hot flushes in breast and prostate cancer , 2005, Expert opinion on pharmacotherapy.

[28]  N. Rance,et al.  Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus , 2004, Brain Research.

[29]  S. Gautam,et al.  Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors , 2004, Menopause.

[30]  C. Maggi,et al.  Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases , 2003, Expert opinion on therapeutic targets.

[31]  R. Freedman,et al.  Estrogen raises the sweating threshold in postmenopausal women with hot flashes. , 2002, Fertility and sterility.

[32]  R. Freedman,et al.  Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. , 2000, Fertility and sterility.

[33]  M. Voytko,et al.  The effects of hormone replacement therapy on hypothalamic neuropeptide gene expression in a primate model of menopause. , 1999, The Journal of clinical endocrinology and metabolism.

[34]  I. Bakker,et al.  Measurement of menopausal hot flushes: validation and cross-validation. , 1996, Maturitas.

[35]  W. Young,et al.  Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. , 1991, Endocrinology.

[36]  R R Freedman,et al.  Laboratory and ambulatory monitoring of menopausal hot flashes. , 1989, Psychophysiology.

[37]  R. Casper,et al.  NEUROENDOCRINOLOGY OF MENOPAUSAL FLUSHES: AN HYPOTHESIS OF FLUSH MECHANISM , 1985, Clinical endocrinology.

[38]  K. Lu,et al.  Gonadotropins, estrogens, and adrenal steroids during the menopausal hot flash. , 1980, The Journal of clinical endocrinology and metabolism.

[39]  H. Judd,et al.  Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: standardization of the technique. , 1979, American journal of obstetrics and gynecology.

[40]  B L Reece,et al.  Thermography of menopausal hot flushes. , 1979, Maturitas.

[41]  E. Kraegen,et al.  Carrier solutions for low-level intravenous insulin infusion. , 1975, British medical journal.

[42]  G. W. Molnar,et al.  Body temperatures during menopausal hot flashes. , 1975, Journal of applied physiology.

[43]  B. Rovner,et al.  A Randomized Clinical Trial , 2013 .

[44]  J. Frisk.  Managing hot flushes in men after prostate cancer--a systematic review. , 2010, Maturitas.

[45]  Janet S Carpenter,et al.  Hot flashes and related outcomes in breast cancer survivors and matched comparison women. , 2002, Oncology nursing forum.

[46]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.